Results 241 to 250 of about 7,199,199 (374)

Cost estimation model for isolation and segregation of non‐genetically modified corn and soybeans at country grain elevators

open access: yesCereal Chemistry, Volume 102, Issue 3, Page 451-465, May/June 2025.
Abstract Background and Objective Corn and soybean meal are important ingredients for livestock and poultry feed. Feed producers who wish to produce non‐genetically modified (non‐GM) feed must segregate ingredients, especially corn and soybeans, throughout the supply chain.
Mateus Pizarro   +4 more
wiley   +1 more source

A Very Readily Prepared Ligand for Rhodium Catalysed Propene Hydroformylation.

open access: yesChemistry – A European Journal, Accepted Article.
In the search for an easy‐to‐make ligand that would lead to Rh catalysts that give very rare preferential formation of iso‐butanal from propene hydroformylation, bis‐phosphonites and bis‐phosphoramidites were designed. Catalysts derived from bis‐phosphonites gave the desired low n:isoratios, but were unstable to hydrolysis. A bis‐phosphoramidite ligand
José A. Fuentes   +4 more
wiley   +1 more source

Corn cob pyrolysis: A systematic literature review of methods and applications

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Mapping the research landscape of corn cob pyrolysis. Abstractas The agricultural sector is experiencing a surge in waste generation due to population growth, creating an urgent need to convert byproducts into value‐added products. Maize (Zea mays L.), a leading global crop, produces significant byproducts, such as corn cob, which are often undervalued.
Vilmar Steffen   +5 more
wiley   +1 more source

AI revolution in insurance: bridging research and reality. [PDF]

open access: yesFront Artif Intell
Bhattacharya S   +3 more
europepmc   +1 more source

Evolving Research and Development Landscape for Rare Diseases: Growing Concerns Over Orphan Drug Lag in Japan

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1325-1337, May 2025.
Patients with rare diseases worldwide face substantial unmet therapeutic needs. In Japan, drug lag—delays in drug approval compared to other countries—has resurfaced as a pressing public health issue. This study analyzes orphan drugs (ODs) approved in the United States (US) from 2005 to 2021, examining OD lag trends, and research and development (R&D ...
Kazuaki Enya   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy